Revista Peruana de Endocrinología y Metabolismo.     2002; 5 (1-2) : 23-32





1 . Kahn CR, Smith Rj, Chin WW. Mechanism of action of hormones that act the cell surface. Williams Textbook of Endocrinology, 8a. ed. Wilson j D, Foster DW (ed.) Philadelphia. WB Saunders; 91, 1992. 

2. Brick H, Stimmler L, Had q jr, Arai Y Plasma insulin response to oral and intravenous glucose administration. j Clin Endocrinol 24: 1076, 1964. 

3. Ferrannini E, Locatelli L,jequier E, FelberjP Differential effects of insulin and hyperglucernia on intracelular glucose disposition in man. Metabolism 38:459, 1989. 

4. Del Prato, Ferrannini E, DeFronzo R: Evaluation of insulin sensitivity in man. En: Methods of Diagnostic Research Vol. II: Clinical methods. Clarke Larner and Pohl, Editors. Ed. Wiley Interscience. Charlotevile, Virginia 36, 1986. 

5. Harano Y, Ohgaku S, Hidika H, Haneda K, Kikkawa R, Shigeta Y, Abe H. Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity J. Clin Endocrinol Metab 45:1124, 1977. 

6. Greenfield MS, Doberne L, Kraemer F ToheyT Reaveng. Assessment of insulin resistance with the insulin supression test and the euglycemic clamp. Diabetes 30:387, 1981. 

7. Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 2371214, 1979. 

8. Groop LC, Bonadonna RC, Del Prato S, et al. Glucose and free fatty acid metabolism in non insulin dependet diabetes mellitus:evidence for multiple sites of insuline resistante. J Clin Invest 84:205, 1989. 

9. Gulle G, Haffner S. What is inherited in NIDDM (Abstract Diabetes 39:(Suppl I) 116A) 1990. 

10. Bonadonna RC. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15:318, 1992. 

11. DeFronzo RA. Lilly y Lecture 1987: The triunvirate: Beta cell, muscle, liver: A collusion responsible for NIDDM. Diabetes 37:667, 1988. 

12. Simonson DC. Fasting hyperglycernia in non-insulin dependent diabetes mellitus: Contributions of excesive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387, 1989. 

13. Bjorkman 0, Reichard GA, The disposal of an oral glucose load in healthy subjects. Diabetes 34:580, 1985. 

14. Bonnadona RC. Pathogenesis of NIDDM: A Precarious Balance between Insulin Action and Insulin Secretion. En: International Textbook of Diabetes Mellitus. Alberti KGMM, DeFronzo RA, Keen H, Zimmet P(ed), chichester, Inglaterra, Editorial J. Wiley & Sons 569, 1992. 

15. Quiñones-Galvin A: Obesidad Alla Ricerche du tempsperdu. Med Int Mex (En prensa). 

16. Kolterman OB, InseIJ, Sackow, Olefsky JM. Mechanison of insulin resistance in human obesity: Evidence for receptor and postreceptor defects. J Clin Invest 65:1272, 1984. 

17. Bouchard C. Genetic aspect of human obesity. En: Obesity Biotorp P, Brocloff BN (ed.) Philadelphia, J13 Lippincoit, 343, 1992.

18. Reaven GM, Lerner RL, Stern MP, Farqhuar JW. Role of insulin in enclogenous hypertriglyceridemia. J Clin Invest 46:1756, 1967. 

19. Stern MP, Mitchell BID, Haffner SM. Impact of associated conditions on glycemic control of NIDDM patients. Diabetes Care 508, 1992. 

20. Paolisso G, Ferrannini E, Sgambato S, Varricchio M, D'Onofrio F Hyperinsulinemia in patients with hypercholesterolemia. J Clin End Metab 1992. (En prensa) 

21. Quiñones-Galván A. Insulin sensitivity in familiar hypercholesterolemia. (En prensa). 

22. Modan M, Halkin H. Almog S, et al. Hyperinsulinemia. A link between hypertension obesity and glucose intol­erance, J Clin Invest 75:809, 1985. 

23. Nilsson P, Hyperinsulinernia and other metabolic disturbances in well controlled hypertensive men and women: an epidemiological study of the Dalby population, J Hypertens 8:95 3, 1990. 

24. Rose HG, Insulin as a potent factor influencing blood pressure in amputees. Hypertension 8:793, 1986. 

25. Fournier AM, Blood pressure, insuline and glycemia in non diabetic subject. Am J Med 80:861, 1986. 

26. Haffner SM. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals: The San Antonio Heart Study, Hypertension 20:38, 1992. 

27. Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannini E. Evidence for an association of blood pressure and hyperinsulinernia obese man. J Clin Endocrinol Metab 62:1302, 1986. 

28. Buzzigoli G. Insuline resistance in essential hypertension. No Engl J Med 317:350, 1987. 

29. Natali A. Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension 17:170, 1991. 

30. Laakso M, Asymptornatic atherosclerosis and insulin resistance. Arteriosclerosis and Thrombosis 11: 1068, 1991. 

31. Ferrannini E, Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetología 34:416, 1991. 

32. DeFronzo R, The pathogenesis of non-insuline dependt diabetes.Anupdate. Medicine 61:125, 1982. 

33. Reaven GM. Role of insuline resistance in human disease. Diabetes 37:149, 1988. 

34. Pyorrala K, Plasma insulin as coronary heart disease risk factor: Relationship to other risk factors and pre­dictive value during 9 1/2 year follow-up of the Helsinki Policemen Study Population. Acta Med Scand 70:38, 1985. 

35. Ducimetiere P, Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle aged population. Diabetologia 19: 205, 1980, 

36. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2:154, 1979. 

37. Martin BC, Warram JH, Krolewski AS, et al. Rose of glucose and insuline resistance in developmet of type 11 diabetes mellitus: results of a 25-year follow up study. Lancet 340:925, 1992.



back.gif (71 bytes) Contenido

Volumenes anteriores

Revistas de Salud